<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Adair | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/writerrail99/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/writerrail99/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Adair.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">aff6c6f601856c5cff683325721da27d</guid>
				<title>Adair posted an update: individualized cortical modulation for treating VD in MS [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42200/</link>
				<pubDate>Sun, 09 Feb 2025 08:07:14 -0800</pubDate>

									<content:encoded><![CDATA[<p>individualized cortical modulation for treating VD in MS patients. Results from this study will provide a better understanding of the brain control of neurogenic bladders and lay the foundation for a potential alternative therapy for VD in MS patients and other NLUTD in a larger neurogenic population in the future.</p>
<p> This trial is registered&hellip;<span class="activity-read-more" id="activity-read-more-42200"><a href="http://www.nationalboardinstitute.com/activity/p/42200/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ad39476fbfbae9d06b1620df9b63da44</guid>
				<title>Adair posted an update: However, their final height was not compromised when [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/31471/</link>
				<pubDate>Tue, 28 Jan 2025 16:56:22 -0800</pubDate>

									<content:encoded><![CDATA[<p>However, their final height was not compromised when compared to their family height target. We found pubertal delay in 12%; accelerated/precocious puberty in 13.2%; central and primary hypogonadism in 21.9% and 3.3%, respectively; primary and central hypothyroidism in 23.6% and 14.5%, respectively; thyroid nodules in 7.4%; ACTH deficiency in&hellip;<span class="activity-read-more" id="activity-read-more-31471"><a href="http://www.nationalboardinstitute.com/activity/p/31471/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6401f6218d6d0ca9cc90f902bf0ee3ba</guid>
				<title>Adair became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/31450/</link>
				<pubDate>Tue, 28 Jan 2025 16:54:15 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>